Oxford Biomedica, a leading contract development and manufacturing organisation (CDMO) in cell and gene therapy, has rebranded to OXB as of September 2024. The company unveiled a modernised and more recognisable visual identity, reflecting its evolution into a global pure-play cell and gene therapy CDMO.
The launch of our new brand identity reinforces OXB’s significant transformation into a leading pure-play cell and gene therapy CDMO. This rebranding is more than just a new look – it reflects the global nature of our operations and our deep commitment to the success of our clients’ drug development programmes. As OXB, with our new capabilities and global footprint, we are ideally positioned to communicate our end-to-end services to current and potential clients, and to interact with them from early-stage development through to commercial manufacturing.
Dr. Frank Mathias, Chief Executive Officer of OXB
The former name, Oxford Biomedica, suggested a regional focus, potentially limiting its appeal in the broader market. In contrast, OXB presents a more flexible and universal brand.
Alongside the rebrand, the company acquired the domain OXB.com. Three-letter .com domains are highly prized for their rarity and value, making them particularly sought after by global brands. With all 17,576 possible three-letter .com domains already taken among over 150 million .com registrations, owning one signifies prestige and represents a strong investment in the brand’s future. OXB.com enhances the company’s online presence, credibility, and customer trust, bolstering its global reach and brand recognition.
The right domain names are a valuable investment for any brand. If you’re ready to secure the perfect domain name for your business, reach out to us for assistance. We’re here to help you find and acquire the ideal domain for your brand.
Other resources
branding business domain domain name domain names domains naming OXB OXB.com Oxford Biomedica rebrand
Previous Next